Navigation Links
Arsenal Capital Partners Invests in DG3
Date:4/9/2008

Partners with Management to Create Leading, Full-Service Global Graphic

Communication Services Organization

NEW YORK, April 9, 2008 /PRNewswire/ -- Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle-market specialty industrial, healthcare and financial services companies, today announced that it has completed its acquisition of Diversified Global Graphics Group ("DG3"). Arsenal and the company's management team, led by CEO Dr. Michael Cunningham, acquired DG3 in a proprietary transaction directly from Peter Furlonge the majority shareholder and former Chairman.

DG3 is a leading, global provider of commercial printing and graphic communication services and has annual revenues of $150 million. DG3 markets its services to a diverse base of blue-chip customers in the financial, pharmaceutical, academic and corporate markets, and serves these customers on a global basis from operations in North America, Europe and Asia.

Dr. Michael Cunningham, who founded DG3, formerly known as Cunningham Graphics International Inc. in 1989 and took it public in 1998 (Nasdaq:CGII), recently re-joined the company. Dr. Cunningham, who received his doctorate from New York University, is a Clinical Professor of Entrepreneurship at the San Diego State University College of Business Administration, where he teaches international business strategy and business planning. He is also a Research Professor from Industry at Cal Poly's graphic communications department and an Adjunct Associate Professor at New York University.

The management team and Board of the company will be strengthened with the addition of Laurence H. Bloch as its new Chairman. Mr. Bloch is a publishing industry veteran who most recently was the Chairman of TransWestern Holdings, a leading U.S. telephone directory publisher. At TransWestern, Mr. Bloch was instrumental in growing the business organically and through numerous acquisitions from approximately $35 million to $1.6 billion in enterprise value. Messrs. Cunningham and Bloch, as well as other key members of senior management, will hold significant equity interests in the company. Peter Furlonge, former Chairman of DG3 will remain as an advisor and has made an investment in the company.

Terrence Mullen, a Managing Director of Arsenal Capital, commented, "We are pleased to add DG3 to the Arsenal portfolio of companies. Our priority is to support management's growth strategy as a customer centric provider to select vertical markets and use our prior investment experience in the printing sector to enhance the business and create a leading, full-service global graphic communications company that is differentiated by its focused approach to providing superior customer service."

"Our new partnership with Arsenal will provide us with additional resources that will help us capture the many opportunities that exist to further penetrate global end markets and broaden service offerings to include higher value process and technology-oriented products and services," said Dr. Cunningham. "I look forward to working with Arsenal, my world class management team and my good friend Larry Bloch to continue to build on the accomplishments we have achieved over the past few years in making DG3 the best in class full service global graphic communications company. I am especially pleased with the high level of management participation in this transaction."

Mr. Bloch commented, "DG3 provides a strong platform by which we can grow the business both organically and through targeted acquisitions that will help expand the company's markets geographically and into targeted verticals. The strong management team is supported by a talented and energetic global workforce that will be instrumental in building the business."

Arsenal's investments in this sector include TallyGenicom, a leader in the impact printer industry, and it previous investment in Renaissance Mark, one of the largest North American providers of prime labels and brand imaging solutions to the packaging industry.

Equity financing for the transaction was provided from Arsenal Capital Partners' $500 million Fund II. Debt financing was provided by Bank of America. Kirkland & Ellis LLP was legal advisor to Arsenal Capital.

About Arsenal Capital Partners

Arsenal Capital Partners is a New York-based private equity firm that makes investments in specialty industrial, healthcare and financial services companies. Arsenal makes investments in sectors where the firm has prior knowledge and experience, and targets businesses that have the potential for further value creation by working closely with management to accelerate growth and leverage the firm's operational improvement capabilities. Arsenal currently has $800 million of committed equity capital. For additional information on Arsenal Capital Partners please visit http://www.arsenalcapital.com.

About the DG3 Group

DG3 is a leading provider of global print and graphic communication solutions operating in strategic geographic markets including Jersey City, London, Hong Kong, Tokyo, Sydney, and Manila. DG3 provides comprehensive graphic communication solutions to corporations, financial services firms, pharmaceutical and academic institutions worldwide. For more information please visit http://www.dg3.com.

Contact: Chris Tofalli

Chris Tofalli Public Relations, LLC

914-834-4334


'/>"/>
SOURCE Arsenal Capital Partners
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. TeamStaff Announces Amended Revolving Credit Facility with Sovereign Business Capital
2. Bionovo to Present at the Cambria Capital Investor Meeting
3. Golub Capital Provides $29.5 Million GOLD Facility in Support of the Recapitalization of ExtruMed
4. Capital BlueCross Receives Prestigious Brand Excellence Award From The Blue Cross & Blue Shield Association
5. Super Model Cindy Crawford will be Honored at DKMS Linked Against Leukemia Gala on May 7th at Capitale
6. St. Alcuin Montessori School Announces $5 Million Capital Campaign Gift
7. InforMedix Retains Murdock Capital Partners
8. LifeMasters Strengthens Capital Structure with $15 Million in Funding from Existing Investors
9. Avista Capital Partners Enhances Energy Practice With Appointment of Gerhard Kurz
10. HealthpointCapital, LLC Appoints Stephen H. Hochschuler, M.D. as Clinical Advisor
11. MaxLife Fund Corp. and Capital Growth Planning Inc., sign a joint venture agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... 05, 2016 , ... In sleep, when the defenses of the day are ... of patients with eating disorders is significant self-criticism, and consequently these patients experience this ... regarded as maladaptive means for coping with this unease, but also leads to a ...
(Date:2/5/2016)... ... 2016 , ... California Mobile Kitchens , a company ... latest mobile kitchen model, featuring customizable stainless steel interiors and a new, 26-foot ... use anywhere in the U.S. Many of their units can be seen at ...
(Date:2/5/2016)... ... 05, 2016 , ... Calls Blacklist has just been updated by mobile app ... the developer has fixed known bugs within the app. Calls Blacklist allows its users ... not consuming any of their device’s battery power or memory. It provides a powerful ...
(Date:2/5/2016)... ... ... –This week, Atascadero water heater company First Call Plumbing has ... the report, click here or see below. , There are two ... cons, the type chosen is almost entirely up to personal preference. However, tankless water ...
(Date:2/5/2016)... ... ... one is tired of trying to cram belongings into spare space that just isn’t there, ... unit, but before hastily spending money on a unit, take these tips into consideration. , ... one is often not told when utilizing these services are some tips on how to ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... SPRING, Md. , Feb. 4, 2016 In ... Califf , the FDA,s Deputy Commissioner for Medical Products and ... action plan to reassess the agency,s approach to opioid medications. ... epidemic, while still providing patients in pain access to effective ... The FDA will: , Re-examine the risk-benefit paradigm ...
(Date:2/4/2016)... Mass. , Feb. 4, 2016  Blueprint ... in discovering and developing highly selective investigational kinase ... announced the appointment to its board of directors ... executive with nearly 30 years of industry-related experience. ... Officer of Blueprint Medicines. "Lonnel,s strong strategic experience ...
(Date:2/4/2016)... , Feb. 4, 2016 SONIFI™ Health, ... solutions, today announced that MonteCedro, an innovative retirement ... Engagement System. The system provides a simple and ... access through a tablet PC. ... engagement system provides access to a wide spectrum ...
Breaking Medicine Technology: